Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
Nature Medicine|October 1, 2021
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumorsRachna T Shroff, Pavani Chalasani, Ran Wei, et al.European Journal of Cancer (Oxford, England : 1990)|June 26, 2022
Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysisAaron Shengting Mai, Ainsley Ryan Yan Bin Lee, Ryan Yong Kiat Tay, et al.Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer TherapyRachna T Shroff, Pavani Chalasani, Ran Wei, et al.Journal of Hematology|April 18, 2020
Efficacy of Ibrutinib-Based Regimen in Chronic Lymphocytic Leukemia: A Systematic ReviewMuhammad Sardar, Saad Ullah Malik, Ali Khan, et al.The Lancet. Gastroenterology & Hepatology|March 18, 2018
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-seriesKeri E Lunsford, Milind Javle, Kirk Heyne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract CancersRachna T Shroff, Gentry King, Sarah Colby, et al.Nature Medicine|April 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trialDevalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro, et al.The Lancet. Gastroenterology & Hepatology|July 14, 2019
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 studyMaeve A Lowery, Howard A Burris, Filip Janku, et al.Oncogene|July 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subsetJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.Nature Communications|September 30, 2025
Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlatesValerie S Kalluri, Brandon G Smaglo, Krishnan K Mahadevan, et al.Pageof 10